Mark Eisner, Chief Medical Officer at FIBROGEN INC (FGEN), sold 18,364 shares at $18.78 ($345K) on 2023-04-04, disclosed to the SEC on 2023-04-06.
Open-market sale of $345k FGEN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.78 | 9,182 | $172K | 50.0% |
| 2 | $18.78 | 9,182 | $172K | 50.0% |
| Total | $18.78 avg | 18,364 | $345K | 100% |
| Filing → |
| VIR | SELL | 2025-07-17 | $57K | — | Filing → |
| FGEN | SELL | 2023-06-09 | $35K | — | Filing → |
| FGEN | SELL | 2023-06-05 | $21K | — | Filing → |